![ISPOR 2024 May 5-8, 2024 | Atlanta, GA, USA. Early Registration Rate expires March 28.]({"type":"image" , "src" : "/sda/112343/IJME-March-May.jpg"})
Citations (18)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Carlo Palazzi, Salvatore D’angelo, Michele Gilio, Pietro Leccese, Angela Padula & Ignazio Olivieri. (2017) Golimumab for the treatment of axial spondyloarthritis. Expert Opinion on Biological Therapy 17:1, pages 129-133.
Read now
Read now
Carlo Palazzi, Salvatore D’Angelo, Michele Gilio, Pietro Leccese, Angela Padula & Ignazio Olivieri. (2015) Pharmacological therapy of spondyloarthritis. Expert Opinion on Pharmacotherapy 16:10, pages 1495-1504.
Read now
Read now
Juergen Braun, Xenofon Baraliakos, Frank Heldmann & Uta Kiltz. (2014) Tumor necrosis factor alpha antagonists in the treatment of axial spondyloarthritis. Expert Opinion on Investigational Drugs 23:5, pages 647-659.
Read now
Read now
Articles from other publishers (15)
Hyoun-Ah Kim, Sun-Kyung Lee, Sohee Oh, Eun Hye Park, Yong-Beom Park & Kichul Shin. (2021) Comparison of Retention Rates Between Tumor Necrosis Factor-α Inhibitors in Patients With Ankylosing Spondylitis: Data From the Korean College of Rheumatology Biologics Registry. Frontiers in Medicine 8.
Crossref
Crossref
Lai Shan Tam, James Cheng‐Chung Wei, Amita Aggarwal, Han Joo Baek, Peter P. Cheung, Praveena Chiowchanwisawakit, Leonila Dans, Jieruo Gu, Noboru Hagino, Mitsumasa Kishimoto, Heizel Manapat Reyes, Soosan Soroosh, Simon Stebbings, Samuel Whittle, Swan Sim Yeap & Chak Sing Lau. (2019) 2018 APLAR axial spondyloarthritis treatment recommendations. International Journal of Rheumatic Diseases 22:3, pages 340-356.
Crossref
Crossref
Sonam Kiwalkar, Atul Deodhar & Joachim Sieper. 2019. Axial Spondyloarthritis. Axial Spondyloarthritis
243
258
.
Sonam Kiwalkar, James T. Rosenbaum, Sergio Schwartzman, Jan Peter Dutz & Filip Van den Bosch. 2019. Axial Spondyloarthritis. Axial Spondyloarthritis
157
182
.
Fabrizio Cantini, Laura Niccoli, Carlotta Nannini, Emanuele Cassarà, Olga Kaloudi, Ennio Giulio Favalli, Andrea Becciolini, Martina Biggioggero, Maurizio Benucci, Francesca Li Gobbi, Valentina Grossi, Maria Infantino, Francesca Meacci, Mariangela Manfredi, Serena Guiducci, Silvia Bellando-Randone, Marco Matucci-Cerinic, Rosario Foti, Marcella Di Gangi, Marta Mosca, Chiara Tani, Fabrizio Palmieri & Delia Goletti. (2016) Tailored first-line biologic therapy in patients with rheumatoid arthritis, spondyloarthritis, and psoriatic arthritis. Seminars in Arthritis and Rheumatism 45:5, pages 519-532.
Crossref
Crossref
Chao Chen, XiaoLin Zhang, Lu Xiao, XueSong Zhang & XinLong Ma. (2016) Comparative Effectiveness of Biologic Therapy Regimens for Ankylosing Spondylitis. Medicine 95:11, pages e3060.
Crossref
Crossref
Sarah L. Field, Tathagata Dasgupta, Michele Cummings, Richard S. Savage, Julius Adebayo, Hema McSara, Jeremy Gunawardena & Nicolas M. Orsi. (2015) Bayesian modeling suggests that IL-12 (p40), IL-13 and MCP-1 drive murine cytokine networks in vivo. BMC Systems Biology 9:1.
Crossref
Crossref
Francesco Caso, Luisa Costa, Antonio Del Puente, Matteo Nicola Dario Di Minno, Gelsy Lupoli, Raffaele Scarpa & Rosario Peluso. (2015) Pharmacological treatment of spondyloarthritis: exploring the effectiveness of nonsteroidal anti-inflammatory drugs, traditional disease-modifying antirheumatic drugs and biological therapies. Therapeutic Advances in Chronic Disease 6:6, pages 328-338.
Crossref
Crossref
Alberto Migliore, Emanuele Bizzi, Mauro Bernardi, Andrea Picchianti Diamanti, Bruno Laganà & Lea Petrella. (2014) Indirect Comparison Between Subcutaneous Biologic Agents in Ankylosing Spondylitis. Clinical Drug Investigation 35:1, pages 23-29.
Crossref
Crossref
Xavier Calvet & Juan Vicente Esplugues. (2014) How to Compare Biologic Drugs. Reumatología Clínica (English Edition) 10:6, pages 353-359.
Crossref
Crossref
Xavier Calvet & Juan Vicente Esplugues. (2014) ¿Cómo comparar fármacos biológicos?. Reumatología Clínica 10:6, pages 353-359.
Crossref
Crossref
Vincenzo Bruner, Mariangela Atteno, Angelo Spanò, Raffaele Scarpa & Rosario Peluso. (2014) Biological therapies for spondyloarthritis. Therapeutic Advances in Musculoskeletal Disease 6:3, pages 92-101.
Crossref
Crossref
Antonio Tursi, Walter Elisei, Marcello Picchio, Antonio Penna, Piera Giuseppina Lecca, Giacomo Forti, GianMarco Giorgetti, Roberto Faggiani, Costantino Zampaletta, Giorgio Pelecca & Giovanni Brandimarte. (2014) Effectiveness and safety of infliximab and adalimumab for ambulatory Crohn's disease patients in primary gastroenterology centres. European Journal of Internal Medicine 25:5, pages 485-490.
Crossref
Crossref
Petra Baji, Márta Péntek, Sándor Szántó, Pál Géher, László Gulácsi, Orsolya Balogh & Valentin Brodszky. (2014) Comparative efficacy and safety of biosimilar infliximab and other biological treatments in ankylosing spondylitis: systematic literature review and meta-analysis. The European Journal of Health Economics 15:S1, pages 45-52.
Crossref
Crossref
Marina Amaral de ?vila Machado, Mariana Michel Barbosa, Alessandra Maciel Almeida, V?nia Eloisa de Ara?jo, Adriana Maria Kakehasi, Eli Iola Gurgel Andrade, Mariangela Leal Cherchiglia & Francisco de Assis Acurcio. (2013) Treatment of ankylosing spondylitis with TNF blockers: a meta-analysis. Rheumatology International 33:9, pages 2199-2213.
Crossref
Crossref